Prudential Financial
PCVX icon

Prudential Financial’s Vaxcyte PCVX Stock Holding History

Prudential Financial’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.42M Sell
41,570
-17,755
-30% -$964K ﹤0.01% 1326
2026
Q1 		$3.45M Buy
59,325
+42,900
+261% +$2.33M ﹤0.01% 1085
2025
Q4 		$758K Sell
16,425
-3,041
-16% -$136K ﹤0.01% 1699
2025
Q3 		$701K Sell
19,466
-114,985
-86% -$3.81M ﹤0.01% 1794
2025
Q2 		$5.06M Buy
134,451
+8,035
+6% +$263K 0.01% 898
2025
Q1 		$4.77M Sell
126,416
-1,355
-1% -$108K 0.01% 858
2024
Q4 		$10.5M Buy
127,771
+31,118
+32% +$3.09M 0.01% 596
2024
Q3 		$11M Buy
96,653
+15,315
+19% +$1.38M 0.02% 646
2024
Q2 		$6.14M Buy
81,338
+26,497
+48% +$1.8M 0.01% 840
2024
Q1 		$3.75M Buy
54,841
+18,330
+50% +$1.27M 0.01% 1093
2023
Q4 		$2.29M Buy
36,511
+243
+0.7% +$12.6K ﹤0.01% 1351
2023
Q3 		$1.83M Sell
36,268
-84,332
-70% -$4.16M ﹤0.01% 1436
2023
Q2 		$6.02M Buy
120,600
+78,383
+186% +$3.72M 0.01% 810
2023
Q1 		$1.58M Buy
42,217
+853
+2% +$36.2K ﹤0.01% 1484
2022
Q4 		$1.98M Buy
41,364
+26,933
+187% +$1.06M ﹤0.01% 1311
2022
Q3 		$347K Buy
14,431
+265
+2% +$6.72K ﹤0.01% 2243
2022
Q2 		$308K Buy
+14,166
New +$328K ﹤0.01% 2333
2022
Q1 		– Sell
-9,920
Closed -$236K – 2669
2021
Q4 		$236K Buy
+9,920
New +$231K ﹤0.01% 2487

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Prudential Financial's PCVX Position: Q2 2026 in Review

Prudential Financial reduced its Vaxcyte (PCVX) stake by 30% in Q2 2026, selling an estimated $964K and leaving 41,570 shares worth $2.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1326.

Prudential Financial first reported a position in PCVX in Q4 2021 and has held it in 18 quarters since. The position peaked at $11M in Q3 2024. 332 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Prudential Financial held 41,570 shares of Vaxcyte worth $2.42M as of Q2 2026.
  • Prudential Financial sold 17,755 Vaxcyte shares in Q2 2026, an estimated $964K.
  • Vaxcyte made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1326 holding.
  • Prudential Financial first reported a position in Vaxcyte in Q4 2021 and has held it in 18 quarters since.
  • Prudential Financial's Vaxcyte position peaked at $11M in Q3 2024.
  • 332 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.